Zydus Wellness Ltd
Zydus Wellness Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Comfort Click: Expected to maintain strong growth trajectory post-acquisition; expanding presence in Europe and new markets like the U.S. Comfort Click became EPS accretive in Q4 FY26 and is expected to remain so, aiming for continued accretive impact by FY27.
From Zydus Wellness Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Comfort Click: Expected to maintain strong growth trajectory post-acquisition; expanding presence in Europe and new markets like the U.S. and UAE with a focus on online platforms such as Amazon and Boots.com.
- Seasonal Portfolio: Though impacted by delayed summer seasonality in recent quarters, recovery is anticipated from May onwards; medium to long-term outlook remains positive for double-digit growth over 3-4 years.
- Food & Nutrition (RiteBite): Continuing high growth momentum beyond the 25% CAGR pre-acquisition, driven by category expansion, new product launches (e.g., RTD beverages, snacks), and distribution ramp-up including quick commerce.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Zydus Wellness Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No explicit mention of current or future capex or strategic capital investments was discussed in the transcript.
- Management indicated appropriate allocation of funds to brands with no major changes planned: "I think our allocation of funds are appropriate to the brand... no other plans or any other changes to the business."
- There were no plans to divest any slow-growing product categories to reallocate capital.
2 more points management made on capital expenditure plans
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Zydus Wellness Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Zydus Wellness Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.5K Cr, net profit ₹162 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Zydus Wellness's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Food Products this season
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Prataap Snacks Ltd (Q4 FY26)
Q4 FY26 revenue from operations was ₹418.1 crore (₹4,180.6 Mn), up 4.9% YoY from ₹398.5 crore (₹3,985.2 Mn) in Q4 FY25. Key concall takeaways from Prataap…
- Proventus Agrocom Ltd (Q4 FY26)
Reported revenue for FY26: ₹659 Cr, a ~58% increase YoY vs FY25 (Page 26, 14). Key concall takeaways from Proventus Agrocom Ltd's Q4 FY26 earnings call — and…
Frequently Asked Questions
What were Zydus Wellness Ltd Q4 FY26 results?
Comfort Click: Expected to maintain strong growth trajectory post-acquisition; expanding presence in Europe and new markets like the U.S. Comfort Click became EPS accretive in Q4 FY26 and is expected to remain so, aiming for continued accretive impact by FY27.
What is Zydus Wellness Ltd share price analysis?
Zydus Wellness Ltd currently shows a neutral. The stock trades at a P/E of 76.2 with a market cap of ₹16,875 Cr. Investors should review the full earnings analysis for detailed insights.
Is Zydus Wellness Ltd planning capital expenditure?
No explicit mention of current or future capex or strategic capital investments was discussed in the transcript. - Management indicated appropriate allocation of funds to brands with no major changes planned: "I think our allocation of funds are appropriate to the brand...
Keep Zydus Wellness Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
